ROR1 is thought to be an attractive biomarker in breast cancer, primarily for TNBC and its subtypes, and increases metastasis by activating various oncogenic signaling pathways, including PI3K/AKT, Hippo, and MEK/ERK pathways [23,24,25]. This evidence concerns the gene ROR1 and breast carcinoma.